Rosa Royo-Nieto

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Biochemical characteristics of inhaled antibiotics related to tolerability.

Biochemical characteristics of inhaled antibiotics related to tolerability.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: January 27, 2025

Safety and effectiveness of treatment with elexacaftor, tezacaftor and ivacaftor in adults with cystic fibrosis

Safety and effectiveness of treatment with elexacaftor, tezacaftor and ivacaftor in adults with cystic fibrosis

Journal: Medicina clinica
Published: January 13, 2023

Safety and tolerability of inhaled antibiotics in patients with bronchiectasis.

Safety and tolerability of inhaled antibiotics in patients with bronchiectasis.

Journal: Pulmonary pharmacology & therapeutics
Published: September 20, 2021

Predictive value of the modified Bhalla score for assessment of pulmonary exacerbations in adults with cystic fibrosis.

Predictive value of the modified Bhalla score for assessment of pulmonary exacerbations in adults with cystic fibrosis.

Journal: European radiology
Published: December 08, 2019

Effect of Sex Differences on Computed Tomography Findings in Adults With Cystic Fibrosis: A Multicenter Study.

Effect of Sex Differences on Computed Tomography Findings in Adults With Cystic Fibrosis: A Multicenter Study.

Journal: Archivos de bronconeumologia
Published: August 07, 2019

Ulcerative Colitis and Bronchiectasis: Can Treatment with Tofacitinib Have an Impact on Respiratory Symptoms?

Ulcerative Colitis and Bronchiectasis: Can Treatment with Tofacitinib Have an Impact on Respiratory Symptoms?

Journal: Archivos de bronconeumologia
Published: July 05, 2019

COPD Assessment Test in Bronchiectasis: Minimum Clinically Important Difference and Psychometric Validation: A Prospective Study.

COPD Assessment Test in Bronchiectasis: Minimum Clinically Important Difference and Psychometric Validation: A Prospective Study.

Journal: Chest
Published: March 14, 2019

Acute severe pulmonary toxicity due to biosimilar infliximab in a Crohn's disease patient.

Acute severe pulmonary toxicity due to biosimilar infliximab in a Crohn's disease patient.

Journal: Gastroenterologia y hepatologia
Published: September 14, 2017

Respiratory infections due to nontuberculous mycobacterias.

Respiratory infections due to nontuberculous mycobacterias.

Journal: Medicina clinica
Published: July 11, 2017
Showing 1-9 of 9

Last Updated: 09/26/2026